Be Well Medical Center

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• HIV5 trials
• Hepatitis B1 trial

Phase

• Phase 34 trials
• Phase 21 trial

Status

• Active, not recruiting3 trials
• Recruiting2 trials
• Completed1 trial

Lead sponsor

• Gilead Sciences6 trials

Running trials

• Recruiting

  Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy

  NCT07682961· Phase 3· Gilead Sciences· Source

• Recruiting

  Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention

  NCT07473778· Gilead Sciences· Source

• Active, not recruiting

  Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP)

  NCT07047716· Phase 3· Gilead Sciences· Source

• Active, not recruiting

  Study Evaluating the Safety and Efficacy of Islatravir in Combination With Lenacapavir in Virologically Suppressed People With HIV

  NCT05052996· Phase 2· Gilead Sciences· Source

• Active, not recruiting

  Pre-Exposure Prophylaxis Study of Lenacapavir in Cisgender Men, Transgender Women, Transgender Men, and Gender Nonbinary People at Risk for HIV Infection

  NCT04925752· Phase 3· Gilead Sciences· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• HIV2 recruiting

Closed trials

• Completed

  Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected Adults

  NCT03547908· Phase 3· Gilead Sciences· Source